Gefticip 250mg Tablets

Product Details:

Supply Ability : 100 Box Per Day
Share Your Product:

68 USD ($)/Box

Get a Price/Quote

Request To Call Back Send Inquiry

Price And Quantity

Price Range 68.00 - 68.00 USD ($)/Box
Price 68 USD ($)/Box
Minimum Order Quantity 1 Box

Trade Information

FOB Port ANY INDIAN PORT
Payment Terms Cash in Advance (CID), Telegraphic Transfer (T/T), Paypal
Supply Ability 100 Box Per Day
Delivery Time 5 Days
Sample Policy Sample costs shipping and taxes has to be paid by the buyer
Packaging Details 10 tablets in 1 stripes
Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Main Domestic Market All India
Certifications na

Product Description

Medicine Details:

Brand Name : Gefticip 250mg
Active Ingredients : Gefitinib 250mg
Manufacturer : Natco
Strength: 250mg
Packing: Pack of 30 Tablets & Pack of 10 Tablets

Enter Buying Requirement Details

+ Add Attachment

Email Id

Mobile number

Please Wait...

Other Products in 'Critical Care Products' category

Fempro 2.5mg Tablets Price : 1 USD ($)/Box Minimum Order Quantity : 1 Recommended For : AS PER PHYSICIAN Physical Form : Tablets Storage Instructions : NORMAL ROOM TEMP Dosage Guidelines : AS PER PHYSICIAN DIRECTION Function : AntiCancer Ingredients : Medicine Details:Brand Name : FemproManufacturer : CiplaStrength: 2.5 mgPacking: Pack of 10 Tablets Dosage : AS PER PHYSICIAN Drug Type : General Medicines Quantity : 1 Boxes

Send Inquiry

Soranib Tablets Price : 24.18 USD ($)/Bottle Minimum Order Quantity : 1 Recommended For : AS PER PHYSICIAN Physical Form : Tablets Storage Instructions : NORMAL ROOM TEMP Dosage Guidelines : AS PER PHYSICIAN DIRECTION Function : AntiCancer Ingredients : Holding a highly reputed and trusted market standing, we are engaged in offering Soranib Tablets. These tablets are used in the treatment of kidney cancer, thyroid cancer and liver cancer Dosage : AS PER PHYSICIAN Drug Type : General Medicines Quantity : 30 Pieces

Send Inquiry